Intravenous and oral protein alimentation using hydrolysates of casein for treatment and prevention of protein deficiency states is receiving increasing recognition. Emphasis has been centered around nitrogen metabolism in such surgical conditions as shock (1), burns (2), blood loss (3, 4), wound healing (5, 6, 7), convalescence (8, 9) , and postoperative infections (10, 11 During the course of previous investigations in this hospital it was observed that individuals who received intravenous injections of an acid hydrolysate of casein ("Parenamine") failed to eat the normal amount of food at the subsequent meal and many complained of loss of appetite. Reports of the occurrence of nausea, vomiting and anorexia associated with the administration of protein hydrolysates are common (12, (16) (17) (18) (19) (20) (21) (22) (23) . The symptoms of intolerance to these, preparations occur most frequently upon rapid injection and constitute one of the disadvantages to their practical use.
Intravenous and oral protein alimentation using hydrolysates of casein for treatment and prevention of protein deficiency states is receiving increasing recognition. Emphasis has been centered around nitrogen metabolism in such surgical conditions as shock (1), burns (2) , blood loss (3, 4) , wound healing (5, 6, 7), convalescence (8, 9) , and postoperative infections (10, 11) . Numerous investigations (12 to 15) have shown that positive nitrogen balance can be maintained for short periods of time in patients receiving intravenous amino acid mixtures as the only source of protein. Another of the major indications for parenteral nitrogen feedings is in patients with debilitating diseases who are unable or unwilling to take adequate food by mouth. In such cases the aim is to supplement the oral nitrogen intake by the use of intravenous protein hydrolysates to provide for the restoration of depleted protein reserves and the daily protein requirements.
During the course of previous investigations in this hospital it was observed that individuals who received intravenous injections of an acid hydrolysate of casein ("Parenamine") failed to eat the normal amount of food at the subsequent meal and many complained of loss of appetite. Reports of the occurrence of nausea, vomiting and anorexia associated with the administration of protein hydrolysates are common (12, (16) (17) (18) (19) (20) (21) (22) (23) . The symptoms of intolerance to these, preparations occur most frequently upon rapid injection and constitute one of the disadvantages to their practical use.
Since nausea, vomiting, and anorexia following the infusion of protein digests might result in a decrease in food intake, the advantages offered by intravenous alimentation could thus be offset by a decrease in the consumption of food. The present investigation was undertaken to determine to what extent the administration of solutions of amino acid mixtures would influence the voluntary food intake in normal individuals. Studies were also carried out on the relationship of the rate of injection of amino acid mixtures to the occurrence of anorexia, nausea, and vomiting.
EXPERIMENTAL
Eight normal healthy adult males and 1 patient with portal cirrhosis were chosen for this study. They were permitted to be ambulatory except for the time required to complete the infusions. Each subject was offered a standard diet which supplied 3,544 calories. It contained approximately 135 grams of protein, 180 grams fat and 347 grams carbohydrate. Each item of uneaten food was weighed and the amount consumed was calculated as the difference between the weight of food offered and the weight of that returned. The items in the diet were varied to permit some choice. From the weight of the food consumed it was possible to calculate by the use of standard reference tables (24) the total calories and the amount of fat, carbohydrate, and protein consumed each day.
The general plan of the study was to keep the subject on the diet for a few days, then give amino acid preparations either orally or intravenously along with the diet, and note any effect on the food consumption. The days during which added protein was given will be referred to in this report as the experimental period; it lasted from 3 to 7 successive days when the supplemental protein was given orally and from 3 to 6 successive days, usually 3, when it was given intravenously. The subjects were under continuous observation for from 21 to 35 days. Each individual was studied for at least 2 experimental periods each of which was preceded and followed by control periods of not less than 3 days. Three amino acid preparations were used and they will be designated mixture I, II, and II. 
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The sequence of amino acid mixtures used during the successive experimental periods was varied, as shown in Figures 1A, 1B and 2 . Two subjects received only one of the mixtures, 7 subjects received 2 mixtures, and 2 of the subjects also received a 10 per cent glucose solution and physiological saline solution interspersed with the solutions of amino acid mixtures in order to obtain information on the effect that these solutions had on the food consumption ( Figure 1B ). In 4 subjects the effect of using casein hydrolysates by the oral route was investigated for 5 experimental periods and in these studies only mixture I was used.
The amount of mixtures given on each experimental day was equivalent to 100 grams of protein. (Table  II) .
RESULTS
The results of the influence of oral and intravenous protein supplemental feedings on the amount of food voluntarily consumed during all of the control and experimental periods are summarized on Table I and Figures 1A, 1B, and 2. It can be seen that during the control period when the only source of food was the basal diet, the daily caloric intake remained relatively constant in all subjects. It is also evident that when amino acid Mixture I was given by mouth as the supplemental feeding ( Figure 1A ) there was little effect on the amount of food eaten. These changes, expressed as calories consumed per day, are interpreted as not being significant. Five subjects received amino acid Mixture I parenterally, and, of these, 4 had little or no depression of the caloric intake. The one patient in whom a depression of appetite occurred (Case No. 2, Figure 1A ), had an intake of 67 per cent of the basic control diet. In sharp contrast are the results which occurred in all 7 subjects who received amino acid Mixture II by the intravenous route. There was a constant reduction in the food voluntarily consumed; the average fall was to 61 per cent of the normal con- (Table II) . This reduction occurred in each of 2 experimental periods in 1 subject (Patient 9, Figure 2 ) when he was given this preparation. The same results followed the giving of this solution irrespective of whether its use preceded or followed the other 2 mixtures. Amino acid Mixture III was administered to 3 men (Patients 6, 7, and 8, Figure 2 ) and no measurable change of food consumption occurred during or following the preparation. Ten Figure 1B . These 2 commonly employed solutions produced little effect upon the appetite of these men.
In many experimental periods, notably with patients Nos. 2, 4, 5, 6, and 7, there occurred a stepwise depression of food consumption with each additional day during the infusion of supplementary protein. In some instances this progressive depression extended into the first or even the second day of the following control period. This tendency toward a progressive loss of appetite on the last days of the experimental periods and a lag or overlap into the subsequent control period was particularly notable with the use of Mixture II; it occurred to a lesser degree with Mixture I, and was not observed with Mixture III.
It was observed that an important factor which influenced the consumption of food in these subjects was the reactions occurring with or soon after the subject received the amino acid mixture. In the case of amino acid Mixture III no reactions occurred, but Mixture II produced nausea and vomiting in many of the subjects. Another important complaint of the persons receiving the latter preparation was a burning sensation in the arm while receiving the mixture. The burning extended up the arm along the vein to the axilla and was occasionally followed by thrombophlebitis. (9) has pointed out that one of the major drawbacks to the clinical use of casein hydrolysates for intravenous protein feedings is the difficulty in giving enough to supply the nitrogen and caloric needs. This is particularly true if it is desired to give large amounts of protein building materials. Elman (25) , in presenting a regime for intravenous alimentation of patients suf- fering from severe protein deficiency, advised the giving of both amino acids and glucose. The sum of the volumes of solutions given per 24-hour period amounted to 3,000 ml., and the total caloric intake was only 1,200 calories, an amount which usually would not be sufficient for a normal subject to maintain his weight. In this investigation the daily dose of the equivalent of 100 grams of protein was arbitrarily chosen because it was considered an amount adequate to provide the generally recommended allowance of 1 gram of protein per kilogram of body weight and a margin to replace depleted protein reserves.
A practical consideration in giving intravenous protein supplements is to employ a method that will not interfere with the patient's daily food intake. In this study 3 injections were given daily, and the individual infusions were completed in not more than 3 hours. Longer infusions were considered inadvisable from the standpoint of comfort to the patient and because the presence of the needle in the vein was a factor which mechanically interfered with the eating of the regular meals. The rates used with Mixture I and II exceeded those usually recommended. Mixture III was frequently given at rates twice those used with the casein digests. The data regarding the rate of infusion in the present study do not permit any final conclusions.
One of the requirements for an acceptable intravenous preparation is that it must be injectable in adequate amounts without producing nausea, vomiting, or other unpleasant reactions. The relationship of reactions which occurred during or following the infusions to the depression of the appetite is a matter of great practical importance. The one constant finding was that, of the 3 mixtures used, the greatest impairment in the appetite occurred during those experimental periods when Mixture II was given. However, it is noteworthy that none of the subjects given Mixture III had any side-effects, and in this same group no significant reduction in the consumption of food was observed. When these same patients received Mixture II impairment of the appetite occurred.
At the present time there is no satisfactory explanation for the occurrence of nausea and vomiting. Albanese (26) questioned if these toxic effects were due to unnatural isomers of certain amino acids which cannot be utilized by the human body. Hopps (27) suggests that the presence of some histamine-like substances, peptones or tyramine as agents may explain the frequently observed reactions of flushing, sensation of warmth, and nausea; but he gives no experimental data to support these ideas. Madden and associates (22) have shown that both glutamic and aspartic acids when added to a mixture of pure amino acids will cause violent vomiting in dogs. The effect of these 2 amino acids upon the voluntary food consumption and as a factor causing emesis in humans is being investigated and will be reported in a separate communication. Hoffman, Kozoll, and Osgood (28) have presented evidence that the height of the amino acid nitrogen content of the blood is probably the factor responsible for producing nausea. They found that if the rate is sufficiently rapid to get a blood amino acid nitrogen value of 10 mgm. per cent or greater, nausea will result. These studies were carried out using Mixture II. Hecht (21), using Mixture II, has suggested that perhaps the rapidity of the rise of the amino acid blood levels and not the actual levels themselves were responsible for the side effects.
The progressive step-wise reduction in the amount of food voluntarily consumed during the succeeding days of the experimental periods occurred with such regularity, particularly with Mixture II, that it must be considered more than a chance occurrence. The overlap into the subsequent first and second days of the control period and the gradual recovery were the usual findings in these cases. At present there is no explanation for this occurrence.
These studies raise the question as to whether the advantages of giving large doses of amino acid mixtures intravenously are offset by increased urinary nitrogen "wastage" which would be expected to accompany the rapid rates of infusion. In the search for a more acceptable preparation for intravenous use, this important point will require investigation.
SUMMARY
The effect of the oral and intravenous administration of mixtures of amino acids on the volun-tary food consumption in normal human subjects was studied. Three preparations were used: an enzymic hydrolysate of casein (I), an acid hydrolysate of casein (II), and a mixture of the 10 essential amino acids plus glycine (III). The enzymic digest had little effect on the appetite whether it was given orally or intravenously. The acid hydrolysate of casein consistently produced a marked depression in the voluntary food consumption during and following its intravenous administration. The mixture of the essential amino acids had no depressing effect on the appetite. This product was the best tolerated of the 3 tested and could be given at exceedingly rapid rates without any ill effects. When there was reduction in the amount of food eaten, it consisted of a general lack of interest in food rather than a selective rejection of a certain class of foodstuff. 
